Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
23.61
+0.33 (1.42%)
Jul 15, 2025, 3:00 PM CST

Nanjing Vazyme Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2018 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
9,3918,81112,80821,25742,401-
Upgrade
Market Cap Growth
2.56%-31.21%-39.74%-49.87%--
Upgrade
Enterprise Value
7,5746,99510,67018,87741,383-
Upgrade
Last Close Price
23.6122.0231.6150.47100.29-
Upgrade
PE Ratio
---35.7762.51-
Upgrade
Forward PE
98.3843.6948.0323.2157.10-
Upgrade
PS Ratio
6.906.409.965.9622.69-
Upgrade
PB Ratio
2.412.233.184.6110.27-
Upgrade
P/TBV Ratio
2.552.373.374.8010.32-
Upgrade
P/FCF Ratio
----119.49-
Upgrade
P/OCF Ratio
559.03-83.7228.9168.74-
Upgrade
EV/Sales Ratio
5.565.088.305.2922.15-
Upgrade
EV/EBITDA Ratio
---20.6654.37-
Upgrade
EV/EBIT Ratio
---22.2056.70-
Upgrade
EV/FCF Ratio
-180.81---116.63-
Upgrade
Debt / Equity Ratio
0.280.190.320.100.020.00
Upgrade
Debt / EBITDA Ratio
101.2629.87-0.470.120.00
Upgrade
Debt / FCF Ratio
----0.260.00
Upgrade
Asset Turnover
0.260.260.220.670.601.62
Upgrade
Inventory Turnover
1.191.241.454.592.081.97
Upgrade
Quick Ratio
2.943.502.533.569.765.22
Upgrade
Current Ratio
3.333.952.783.9610.465.83
Upgrade
Return on Equity (ROE)
-0.57%-0.49%-1.69%13.58%24.85%107.25%
Upgrade
Return on Assets (ROA)
-1.48%-1.31%-2.89%10.02%14.67%61.66%
Upgrade
Return on Capital (ROIC)
-1.57%-1.41%-3.27%11.44%16.43%76.07%
Upgrade
Return on Capital Employed (ROCE)
---17.50%17.30%69.60%
Upgrade
Earnings Yield
-0.23%-0.21%-0.55%2.80%1.60%-
Upgrade
FCF Yield
-0.45%-0.96%-0.62%-1.07%0.84%-
Upgrade
Dividend Yield
1.29%0.82%0.32%2.48%0.30%-
Upgrade
Payout Ratio
---22.25%0.66%0.18%
Upgrade
Buyback Yield / Dilution
23.47%8.20%1.16%-9.95%-1.97%-
Upgrade
Total Shareholder Return
24.75%9.02%1.47%-7.48%-1.67%-
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.